HSD3B2, HSD17B1, HSD17B2, ESR1, ESR2 and AR expression in infertile women with endometriosis
Abstract
Objectives: The development of endometriosis is associated with changes in the expression of genes encoding the 3β-hydroxysteroid dehydrogenase type II (HSD3B2) and 17β-hydroxysteroid dehydrogenase type II (HSD17B2), estrogen receptors 1 (ESR1) and 2 (ESR2) and the androgen receptor (AR). However, little is known about the expression of HSD3B2, HSD17B1, HSD17B2, ESR1 ESR2 and AR during the endometrial phases in eutopic endometrium from infertile women with endometriosis.
Material and methods: Using RT-qPCR analysis, we assessed the expression of the studied genes in the follicular and luteal phases in eutopic endometrium from fertile women (n = 17) and infertile women (n = 35) with endometriosis.
Results: In the mid-follicular eutopic endometrium, we observed a significant increase in HSD3B2 transcript levels in all infertile women with endometriosis (p = 0.003), in infertile women with stage I/II endometriosis (p = 0.008) and in infertile women with stage III/IV endometriosis (p = 0.009) compared to all fertile women. There was a significant increase in ESR1 transcripts in all infertile women with endometriosis (p = 0.008) and in infertile women with stage I/II endometriosis (p = 0.019) and in infertile women with stage III/IV endometriosis (p = 0.023) compared to all fertile women. In the mid-luteal eutopic endometrium, we did not observe significant differences in HSD3B2, HSD17B1, HSD17B2, ESR1, ESR2 and AR transcripts between infertile women with endometriosis and fertile women.
Conclusions: Observed significant increase in HSD3B2 and ESR1 transcripts in follicular eutopic endometrium from infertile women with endometriosis may be related to abnormal biological effect of E2 in endometrium, further affecting the development of human embryos.
Keywords: fertilityendometriosisgenes expression
References
- Luca A, Nemescu D, Butnaru M, et al. Ovarian stimulation outcome in infertile women with endometriosis undergoing IVF. Ginekol Pol. 2016; 87(1): 37–41.
- Zubrzycka A, Zubrzycki M, Janecka A, et al. New Horizons in the Etiopathogenesis and Non-Invasive Diagnosis of Endometriosis. Curr Mol Med. 2015; 15(8): 697–713.
- Vercellini P, Viganò P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014; 10(5): 261–275.
- Wilczyński M, Wiecka-Płusa M, Antosiak B, et al. [Rectovaginal endometriosis--analysis of 160 cases]. Ginekol Pol. 2015; 86(12): 896–901.
- Ianieri MM, Mautone D, Ceccaroni M. Recurrence in Deep Infiltrating Endometriosis: A Systematic Review of the Literature. J Minim Invasive Gynecol. 2018 [Epub ahead of print].
- Krishnamoorthy K, Decherney AH. Genetics of Endometriosis. Clin Obstet Gynecol. 2017; 60(3): 531–538.
- Jurkiewicz-Przondziono J, Lemm M, Kwiatkowska-Pamuła A, et al. Influence of diet on the risk of developing endometriosis. Ginekol Pol. 2017; 88(2): 96–102.
- Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 2017; 96(6): 659–667.
- Borghese B, Zondervan KT, Abrao MS, et al. Recent insights on the genetics and epigenetics of endometriosis. Clin Genet. 2017; 91(2): 254–264.
- Attar E, Tokunaga H, Imir G, et al. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab. 2009; 94(2): 623–631.
- Urata Y, Osuga Y, Akiyama I, et al. Interleukin-4 and prostaglandin E2 synergistically up-regulate 3β-hydroxysteroid dehydrogenase type 2 in endometrioma stromal cells. J Clin Endocrinol Metab. 2013; 98(4): 1583–1590.
- Huhtinen K, Saloniemi-Heinonen T, Keski-Rahkonen P, et al. Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions. J Clin Endocrinol Metab. 2014; 99(11): E2188–E2197.
- Smuc T, Pucelj MR, Sinkovec J, et al. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol Endocrinol. 2007; 23(2): 105–111.
- Coakley FV, Varghese SL, Hricak H. CT and MRI of pelvic varices in women. J Comput Assist Tomogr. 1999; 23(3): 429–434.
- Szczepańska M, Wirstlein P, Skrzypczak J, et al. Polymorphic variants of CYP17 and CYP19A and risk of infertility in endometriosis. Acta Obstet Gynecol Scand. 2013; 92(10): 1188–1193.
- Hoeger K, Guzick D. CLASSIFICATION OF ENDOMETRIOSIS. Obstetrics and Gynecology Clinics of North America. 1997; 24(2): 347–359.
- Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975; 122(2): 262–263.
- Goswami AM. Structural modeling and in silico analysis of non-synonymous single nucleotide polymorphisms of human 3β-hydroxysteroid dehydrogenase type 2. Meta Gene. 2015; 5: 162–172.
- Delvoux B, D'Hooghe T, Kyama C, et al. Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions. J Clin Endocrinol Metab. 2014; 99(1): 276–284.
- Young SL. Oestrogen and progesterone action on endometrium: a translational approach to understanding endometrial receptivity. Reprod Biomed Online. 2013; 27(5): 497–505.
- Sanchez AM, Somigliana E, Vercellini P, et al. Endometriosis as a detrimental condition for granulosa cell steroidogenesis and development: From molecular alterations to clinical impact. J Steroid Biochem Mol Biol. 2016; 155(Pt A): 35–46.
- Zeitoun K, Takayama K, Sasano H, et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab. 1998; 83(12): 4474–4480.
- Bulun SE, Monsivais D, Kakinuma T, et al. Molecular biology of endometriosis: from aromatase to genomic abnormalities. Semin Reprod Med. 2015; 33(3): 220–224.
- Sukocheva OA. Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet? World J Gastroenterol. 2018; 24(1): 1–4.
- Catanuto P, Xia X, Pereira-Simon S, et al. Estrogen receptor subtype ratio change protects against podocyte damage. Curr Trends Endocinol. 2017; 9: 19–29.
- Powles TJ. Anti-oestrogenic prevention of breast cancer--the make or break point. Nat Rev Cancer. 2002; 2(10): 787–794.
- Hamilton KJ, Hewitt SC, Arao Y, et al. Estrogen Hormone Biology. Curr Top Dev Biol. 2017; 125: 109–146.
- Monteiro JB, Colón-Díaz M, García M, et al. Endometriosis is characterized by a distinct pattern of histone 3 and histone 4 lysine modifications. Reprod Sci. 2014; 21(3): 305–318.
- Khan MA, Sengupta J, Mittal S, et al. Genome-wide expressions in autologous eutopic and ectopic endometrium of fertile women with endometriosis. Reprod Biol Endocrinol. 2012; 10: 84.
- Harris HA, Bruner-Tran KL, Zhang X, et al. A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod. 2005; 20(4): 936–941.
- Shin JJ, Choi YM, Choi HY, et al. Androgen receptor cytosine, adenine, and guanine trinucleotide repeat polymorphism in Korean patients with endometriosis: A case-control study. Eur J Obstet Gynecol Reprod Biol. 2017; 218: 1–4.
